Literature DB >> 8777901

Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: prenatal methylazoxymethanol treatment.

S C Baraban1, P A Schwartzkroin.   

Abstract

Prenatal methylazoxymethanol acetate (MAMac) injection disrupts cell migration in developing rats. We investigated the electrophysiological characteristics of hippocampal CA1 pyramidal neurons from young MAMac-treated animals (postnatal days 25-35). In vitro intracellular recordings from CA1 cells in MAMac-treated tissue revealed resting membrane potential (mean, -61.5 +/- 1.5 mV), action potential amplitude (mean, 69 +/- 3.1 mV), action potential duration (mean, 2.1 +/- 0.2 ms), input resistance (mean, 51.5 +/- 3.6 M omega) and time constant (mean, 33.2 +/- 1.2 ms) similar to those of CA1 cells from control tissue. However, MAMac-treated tissue could be distinguished as having a higher percentage of cells (62% vs. 10%) which fire a burst of action potentials in response to suprathreshold current injection. The synaptic responses of CA1 cells in MAMac-treated and control tissue were comparable. The CA1 field response to stimulation was also comparable at all stimulus intensities tested (50-1500 microA). Elevation of extracellular potassium concentration ([K+]o) from 3 mM to 6 mM resulted in epileptiform discharge activity in response to stratum radiatum stimulation in all MAMac-treated slices (10/10) but in only one-third of controls (3/9). Spontaneous epileptiform discharges were also observed in the majority (8/13) of MAMac-treated slices bathed in 6 mM KCl but in no controls. These data suggest that MAMac treatment during fetal development not only disrupts normal anatomical organization but also leads to alterations in electrophysiological features of the hippocampal CA1 pyramidal cell region. As such, the MAMac model may provide insights into early onset seizure syndromes associated with developmental abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8777901     DOI: 10.1016/0920-1211(95)00045-3

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

1.  Initiation of epileptiform activity in a rat model of periventricular nodular heterotopia.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Emily T Doisy; Philip A Schwartzkroin
Journal:  Epilepsia       Date:  2011-09-20       Impact factor: 5.864

2.  Epileptogenesis in the Dysplastic Brain: A Revival of Familiar Themes.

Authors:  Scott C. Baraban
Journal:  Epilepsy Curr       Date:  2001-09       Impact factor: 7.500

3.  Embryonic and early postnatal abnormalities contributing to the development of hippocampal malformations in a rodent model of dysplasia.

Authors:  Mercedes Paredes; Samuel J Pleasure; Scott C Baraban
Journal:  J Comp Neurol       Date:  2006-03-01       Impact factor: 3.215

4.  Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia.

Authors:  Susan L Campbell; John J Hablitz
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

5.  Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures.

Authors:  H J Wenzel; C A Robbins; L H Tsai; P A Schwartzkroin
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

6.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

7.  Reduced inhibition in an animal model of cortical dysplasia.

Authors:  W J Zhu; S N Roper
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

8.  Osmolarity modulates K+ channel function on rat hippocampal interneurons but not CA1 pyramidal neurons.

Authors:  S C Baraban; M C Bellingham; A J Berger; P A Schwartzkroin
Journal:  J Physiol       Date:  1997-02-01       Impact factor: 5.182

9.  Animal models of focal cortical dysplasia and tuberous sclerosis complex: recent progress toward clinical applications.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10       Impact factor: 5.864

10.  Upregulation of glutamate receptors in rat cerebral cortex with neuronal migration disorders.

Authors:  Min-Cheol Lee; Jae-Jin Shim; Jae-Hyoo Kim; Myeong-Kyu Kim; Young-Jong Woo; Woong-Ki Chung; Jung-Jin Suh; Sang-Chae Nam; Ji-Shin Lee; Yeong-Seon Kim; Jin-Hee Kim; Hyoung-Ihl Kim
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.